# Outcomes of High-risk Non-muscle Invasive Bladder Cancer Treated With Blue Light Resection

> **NCT06525571** · PHASE3 · RECRUITING · sponsor: **Johns Hopkins University** · enrollment: 200 (estimated)

## Conditions studied

- Bladder Cancer

## Interventions

- **DRUG:** Cysview
- **DEVICE:** Karl Storz D-Light C Photodynamic Diagnostic (PDD) system

## Key facts

- **NCT ID:** NCT06525571
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-20
- **Primary completion:** 2027-01-04
- **Final completion:** 2028-01-04
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-11-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06525571

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06525571, "Outcomes of High-risk Non-muscle Invasive Bladder Cancer Treated With Blue Light Resection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06525571. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*